Avita Medical Inc. (RCEL)
NASDAQ · Healthcare
Avita Medical Inc. EBITDA 2018–2025
Avita Medical Inc. annual/quarterly ebitda history and growth rate from 2018 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Avita Medical Inc. ebitda for the quarter ending March 31, 2026 was -8.2 M, a 27.68% decrease year-over-year.
- Avita Medical Inc. ebitda for the twelve months ending March 31, 2026 was -46.3 M, a 49.59% increase year-over-year.
- Avita Medical Inc. annual ebitda for 2025 was -40.2 M, a 27.55% decrease from 2024.
- Avita Medical Inc. annual ebitda for 2024 was -55.5 M, a 31.99% increase from 2023.
- Avita Medical Inc. annual ebitda for 2023 was -42.0 M, a 56.00% increase from 2022.
- Avita Medical Inc. annual ebitda for 2022 was -26.9 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Avita Medical Inc. EBITDA — FAQ
Avita Medical Inc. (RCEL) ebitda over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see RCEL's ebitda history?
The chart and table above show Avita Medical Inc.'s ebitda by year and by quarter, including the growth rate.